Rohto Pharmaceutical has published the "ROHTO Well-being Report - Integrated Report 2024".

The ROHTO Well-being Report provides a comprehensive overview of financial and non-financial information, including business conditions, performance, corporate governance structure, and environmental and social initiatives, for a wide range of stakeholders, including shareholders and investors.
Our purpose is to energize the world of tomorrow by delivering "health" to people around the world through our products and services, thereby leading all those around us and society towards "well-being." Although the business environment surrounding our group changed significantly in fiscal year 2023, we continue to challenge ourselves in new areas and grow. In this report, we will explain our vision for 2030, the value we aim to deliver to society, and our ESG initiatives toward realizing a sustainable well-being society, focusing on the "ROHTO Group Comprehensive Management Vision 2030"

Our group will continue to value communication with all stakeholders and aim to contribute to a sustainable society and achieve healthy group growth.

The English version is scheduled for release at the end of October.